A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Exploring Hereditary Cancer Among Dying Cancer Patients—A Cross-Sectional Study of Hereditary Risk and Perceived Awareness of DNA Testing and Banking

(2010) John Martin Quillin et al.   Journal of Genetic Counseling

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

(2010) M William Audeh et al.   LANCET

Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations

(2010) Larissa A. Meyer et al.   OBSTETRICS AND GYNECOLOGY

Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer

(2009) Molly S Daniels et al.   GENETICS IN MEDICINE

Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations

(2009) Janice S. Kwon et al.   JOURNAL OF CLINICAL ONCOLOGY

What women with ovarian cancer think and know about genetic testing

(2008) Robin A. Lacour et al.   GYNECOLOGIC ONCOLOGY

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

(2008) Noah D. Kauff et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetics Assessment at the End of Life: Suggestions for Implementation in Clinic and Future Research

(2008) John Martin Quillin et al.   JOURNAL OF PALLIATIVE MEDICINE